[HTML][HTML] Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and …
The rate of detection of thyroid nodules and carcinomas has increased with the widespread
use of ultrasonography (US), which is the mainstay for the detection and risk stratification of …
use of ultrasonography (US), which is the mainstay for the detection and risk stratification of …
Electrolyte‐gated transistors for organic and printed electronics
Here we summarize recent progress in the development of electrolyte‐gated transistors
(EGTs) for organic and printed electronics. EGTs employ a high capacitance electrolyte as …
(EGTs) for organic and printed electronics. EGTs employ a high capacitance electrolyte as …
Robust design: an overview
AS the engineering environment becomes extremely competi-tive, quality products are
required in industries. Unexpected deviations from the function that a designer initially …
required in industries. Unexpected deviations from the function that a designer initially …
[HTML][HTML] Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
SJ Antonia, A Villegas, D Daniel… - … England Journal of …, 2017 - Mass Medical Soc
Background Most patients with locally advanced, unresectable, non–small-cell lung cancer
(NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy …
(NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy …
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Background D2 gastrectomy is recommended in US and European guidelines, and is
preferred in east Asia, for patients with resectable gastric cancer. Adjuvant chemotherapy …
preferred in east Asia, for patients with resectable gastric cancer. Adjuvant chemotherapy …
Dense dislocation arrays embedded in grain boundaries for high-performance bulk thermoelectrics
The widespread use of thermoelectric technology is constrained by a relatively low
conversion efficiency of the bulk alloys, which is evaluated in terms of a dimensionless figure …
conversion efficiency of the bulk alloys, which is evaluated in terms of a dimensionless figure …
[HTML][HTML] Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC
SJ Antonia, A Villegas, D Daniel… - … England Journal of …, 2018 - Mass Medical Soc
Background An earlier analysis in this phase 3 trial showed that durvalumab significantly
prolonged progression-free survival, as compared with placebo, among patients with stage …
prolonged progression-free survival, as compared with placebo, among patients with stage …
[HTML][HTML] Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Background The poly (adenosine diphosphate–ribose) inhibitor talazoparib has shown
antitumor activity in patients with advanced breast cancer and germline mutations in BRCA1 …
antitumor activity in patients with advanced breast cancer and germline mutations in BRCA1 …
[PDF][PDF] Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
LV Sequist, JCH Yang, N Yamamoto… - Journal of clinical …, 2013 - static.vademecum.es
Purpose The LUX-Lung 3 study investigated the efficacy of chemotherapy compared with
afatinib, a selective, orally bioavailable ErbB family blocker that irreversibly blocks signaling …
afatinib, a selective, orally bioavailable ErbB family blocker that irreversibly blocks signaling …
[HTML][HTML] Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
DR Spigel, C Faivre-Finn, JE Gray… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE The phase III PACIFIC trial compared durvalumab with placebo in patients with
unresectable, stage III non–small-cell lung cancer and no disease progression after …
unresectable, stage III non–small-cell lung cancer and no disease progression after …